The DE genes in the response of CD3−/28.4+ IEL-NK to vvIBDV infection, which mainly involved the Toll signalling pathway, inflammatory response, interferon stimulation and cytokine and chemokines pathways, have supported the indication of IEL-NK cell activation as proposed by the upregulation of the activation markers. The gene discussed is TLR4; the disease is infection.